Physical Activity Advices to Prevent Loss of Autonomy in Cancer Treated Elderly Patients. An Intervention Randomized Study
- Conditions
- Elderly PopulationCancer
- Interventions
- Other: Classic physical activitiesOther: Adapted physical activity
- Registration Number
- NCT01432067
- Lead Sponsor
- University Hospital, Bordeaux
- Brief Summary
The investigators will propose to older cancer patients with good prognosis (curative care) a randomized trial of adapted physical activity during one year. To increase generalisation of the intervention the investigators intend to compare the PNNS advices (the French National Nutrition and Health Program) to a program targeted on the own capacities of each patient.
- Detailed Description
Long-term evolution of successful-treated older patients is not well-known except for survival. They seem more affected by physical than psychological problems. The combined effects of aging, cancer, and treatments on muscle function could have hindered their usual physical activity. Cancer is associated with frailty. Fried and coll have defined a frailty phenotype as a combination of 3 or more of 5 conditions: exhaustion, loss of weight, decreased muscle strength, slow gait speed and low physical activity. Frail subjects have a higher risk of physical or cognitive disability and death. An intervention able to prevent frailty is of great interest for the older cancer patient and their quality of life. An intervention consisting of phone-program in physical activity has been associated with a decrease in self-reported disability in five-year obese survivors from cancer.
Patients will be randomized in two arms (1:1 ratio). Arm 1: Physical activity advices according to a program adapted to physical status of the patient assessed using SPPB (short physical performance battery) and the IPAQ questionnaire. A monthly phone support during one year will be performed by an adapted physical activity instructor and delivery of PNNS guide for subjects older than 55 y old. Arm 2: Delivery of PNNS guide for subjects older than 55 year old: recommendation of 1/2 hour physical activity of any kind.
Each patient will be followed during 2 years: First visit (V1) will take place before treatment. The subsequent visits will take place at 3 months (V2), 6 months (V3), 1 year (V4), 18 months (V5) and 2 years (V6), in which patients will complete questionnaires (IPAQ, QLQ-C30, one day dietary intakes), have clinical examinations (weight, performance status/ ECOG) and will be tested for physical facilities (SPPB, micro-fet2). These evaluations will be completed by the MMS / Fluency tests and the covered distance during 6 minutes at V1, V3, and V4.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 302
-
70 years old or older
-
Curative cares for cancer by chemotherapy and/ or surgery and/or hormonotherapy and/ or radiotherapy
-
Patient with histologically proven lymphoma or carcinoma :
- Colon, rectum or anal canal Cancer
- Breast Cancer
- Esophageal cancer
- Otolaryngology Cancer
- Kidney cancer
- hepatocellular carcinoma
- Stomach Cancer
- Pancreatic cancer
- Bile duct cancer
- Ovarian Cancer
- All lymphoma diffuse large B-cell and all peripheral T-cells lymphomas
- All low-grade lymphoma: lymphocytes, lymphocytes and plasma cells, follicular, mantle, marginal zone (MALT and others)
- Prostate cancer
- Bladder Cancer
- Lung cancer
- adenocarcinoma of unknown primary origin compatible with previous quoted origin
-
Performance status (ECOG) <4
-
Patient who had given oral consent to participate in the study
- Palliative cares for cancer
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Standard physical activity Classic physical activities Daily physical activities based on a standard guide Adaptated physical activity Adapted physical activity Physical activity advices adaptated to physical status of patients
- Primary Outcome Measures
Name Time Method Cognitive skills 2 years MMS test, verbal fluency
SPPB Score 1 year The main outcome will be the proportion of subjects with a one-year decreased SPPB score of one point or more in 12.
- Secondary Outcome Measures
Name Time Method nutritional status 2 years Walking distance over 6 minutes inclusion, 6 months and 1 year Quality of life 2 years IPAQ, QLQ-C30, ADL, performance status (ECOG)
isometric muscle strength measures of upper and lower limbs 2 years microfet2 test
weight 2 years SPPB score 2 years
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (12)
CHU de Limoges, Hôpital Dupuytren
🇫🇷Limoges, France
Institut jean Godinot, CLCC Reims
🇫🇷Reims, France
CHU Bordeaux - hôpital Xavier Arnozan
🇫🇷Pessac, France
CH Mont de Marsan
🇫🇷Mont de Marsan, France
Centre Alexis Vautrin CLCC Nancy
🇫🇷Vandœuvre-Les-Nancy, France
CHU Nancy hôpital adulte du brabois
🇫🇷Vandœuvre-Les-Nancy, France
CH de Dax
🇫🇷Dax, France
CHU de Bordeaux - Hôpital Saint André
🇫🇷Bordeaux, France
Institut Bergonié
🇫🇷Bordeaux, France
CHRU Lille
🇫🇷Lille, France
Centre Oscar Lambret, CLCC Lille
🇫🇷Lille, France
Centre hospitalier de Senlis
🇫🇷Senlis, France